Venture capital fund aiming to digitize life sciences launches with $350M

Following a March 2022 rollout, Dimension, a venture capital fund focusing on digital life science, launched its first fund with $350 million to invest.

Advertisement

The fund was founded by three alums of Lux Capital and Obvious Ventures. Dimension will target early state companies specializing in drug discovery platforms, machine learning and software companies in the life sciences field, according to a Jan. 25 Dimension letter to investors.

Addressing questions of economic uncertainty, Dimension said it believes that the “long-term potential of technology and science is independent from market cycles.”

“A generational confluence of advances in software, hardware, machine learning and lab science have created prime conditions for a leap forward in life science capability and productivity,” Dimension said in the letter to investors. “The digitization of life sciences will transform the entire end-to-end journey of medicines.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.